The Real Payoff of the AI Boom May Be Better Medicines
U.S. healthcare spending hit $5.3 trillion in 2024. Enveda's executives argue drug discovery is where AI capacity converts most directly into value and patient outcomes.
Topic
Enveda
Topic
Enveda
Enveda Raises $311 Million in Series E Round
AI-driven natural-medicine biotech Enveda has raised $311 million in a Series E round, one of the larger late-stage biotech finan…
Enveda Closes $311M Series E to Fuel Ambitions
Enveda has closed a $311 million Series E round, one of the year's larger biotech financings, to fund its stated ambition of beco…
Enveda Doubles Valuation to $2B in $311M Series E Round
AI drug discovery startup Enveda raised $311M at a $2B valuation, double its worth from a year ago, to push nature-derived drug c…